NCPDP group racing to recommed tamper-resistant pad rules
April 1 is the deadline for all Medicaid prescriptions to be written on tamper-resistant Rx pads.
Letters: February 11, 2008
Pharmacists speak out about a behind-the-counter class of drugs, pharmacy coupons, and Mevacor going OTC.
Latebreakers: FDA's decision on cough and cold OTCs for kids draws support
Industry supports FDAs decision against OTC cough and cold medicines for children under two
Latebreakers: Antifungal approved for new indication
Mycamine from Astellas Pharma was given a supplemental indication approval
Latebreakers: New recombinant injection approved for growth failure
Sandoz's Omnitrope Pen 5 has been cleared for treating kids with growth failure and adults with growth hormone deficiency on a long-term basis
Latebreakers: Welchol granted approved
Colesevelam approved for new indication
Latebreakers: Patients flooding R.Ph.s with Vytorin questions
Patients asking pharmacists about Vytorin controversy
Latebreakers: New NNRTI antiviral etravirine gets FDA nod
Etravirine approved for treatment of HIV
Latebreakers: AWP is back from the dead
The proposed First DataBank settlement that would have discontinued AWP has been denied by a federal court judge.
Wal-Mart to open in-store clinic in Atlanta, Little Rock, and Dallas
The Clinic at Wal-Mart to open in Atlanta, Little Rock, and Dallas.
NCPDP weighing standards for eMARs in long-term care
The National Council for Prescription Drug Programs is exploring the issue of what standards should be established for electronic medication administration records in long-term care.
Members of 340B program to get windfall from Merck settlement
Merck's $650 million settlement for two Medicaid fraud suits is expected to yield a windfall for participants in the 340B drug discount program.
Actor's death from opioids underscores dangers of prescription drug abuse
The American Society of Addiction Medicine urges physicians to prescribe opioids with care following the death of actor Heath Ledger.
New Mexico considers increasing dispensing fee
New Mexico to vote on dispensing fee bill.
Get ready to usher in these new OTCs
Here are more new otcs that treat everything from aches and pains to chapped lips.
Earn add-on winter sales with medicated skin care
Medicated skin care products are highlighted in this stockchecker article by the Hamacher Group.
New data support combo therapy at outset of hypertension treatment
New studies support the use of fixed dose antihypertensive combination therapy at the outset of hypertension treatment.
Time is now for new pregnancy labeling, says committee
As the 10th anniversary of the FDA's public hearing on pregnancy labeling approached, the Teratology Society once again called for regulations to be enacted.
NCCN's new lung cancer guidelines called a useful reference
NCCN's new guidelines for nonsmall cell lung cancer contain new recommendations relating to drug therapy.
Viewpoint: Should an RX label require a use-by date or an expiration date?
All prescription drugs should have a sell-by date for consistency and patient protection.
New Products February 11, 2008
New brand drugs, generics, and over-the-couter products.
Senate looks to boost e-prescribing
New federal leglsation would mandate electronic prescriptions, dividing healthcare providers even the practice gains more acceptance.
BRACING FOR A SHOWDOWN
Pharmacists have temporarily blocked the Medicaid AMP formula, but a bruising battle still awaits.
JP at large: Viva La France!
Do French pharmacists work as many long hours as Amercian pharmacists? Maybe not, but maybe they have the right idea.
Eye on ethics: Whose prescription is it anyway?
Pharmacists must observe HIPAA regulations and also have a clear duty to warn patients.
Orphan drug gets FDA nod for phenylketonuria
FDA approves a new molecular entity, Kuvan, to treat phenylketonuria.
Latebreakers: Four R.Ph.s win pharmacy history contest
Here are the winners of the Drug Topics' 150th Anniversary history contest
Latebreakers: Wal-Mart enters PBM fray
In a speech to its employees, Wal-Mart CEO signals the company's intention to get into the pharmacy benefit management business
Latebreakers: CMS seeks comments on 2009 letter
The Centers for Medicare & Medicaid Services is seeking comment on the draft of its 2009 call letter for prescription drug plans.